Role of puerarin in the signalling of neuropathic pain mediated by P2X 3 receptor of dorsal root ganglion neurons

Brain Research Bulletin

Volumn 87, Issue 1, 2012, Pages 37-43

  Xu, Changshui ^a   Xu, Wenyuan ^a   Xu, Hong ^a   Xiong, Wei ^a   Gao, Yun ^a   Li, Guilin ^a   Liu, Shuangmei ^a   Xie, Jinyan ^a   Tu, Guihua ^a   Peng, Haiying ^a   Qiu, Shuyi ^a   Liang, Shangdong ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Dorsal root ganglion; Neuropathic pain; P2X 3 receptors; Puerarin

Indexed keywords

BETA ACTIN; MESSENGER RNA; PUERARIN; PURINERGIC P2X3 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE MEDICINE; CHRONIC PAIN; CONTROLLED STUDY; EXPERIMENTAL TEST; FACILITATION; HARGREAVES TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LATENT PERIOD; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPINAL GANGLION; SPRAGUE DAWLEY RAT; TISSUE INJURY; VON FREY TEST; WESTERN BLOTTING;

ANIMALS; GANGLIA, SPINAL; ISOFLAVONES; MALE; NEURALGIA; NEURONS; PAIN MEASUREMENT; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X3; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 84155172059     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.10.007     Document Type: Article

References (59)

1. Alexander K., Niforatos W., Bianchi B., Burgard E.C., Lynch K.J., Kowaluk E.A., Jarvis M.F., van Biesen T. Allosteric modulation and accelerated resensitization of human P2X3 receptors by cibacron blue. J. Pharmacol. Exp. Ther. 1999, 291(3):1135-1142.
2. Benoliel R., Tal M., Eliav E. Effects of topiramate on the chronic constriction injury model in the rat. J. Pain 2006, 7(12):878-883.
3. Blackman P. Shin pain in athletes-assessment and management. Aust. Fam. Physician 2010, 39(1-2):24-29.
4. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 2006, 58:58-86.
5. Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol. Ther. 2006, 110(3):433-454.
6. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 2007, 87(2):659-797.
7. Chen Y., Shu Y., Zhao Z. Ectopic purinergic sensitivity develops at sites of chronic nerve constriction injury in rat. Neuroreport 1999, 10(13):2779-2782.
8. Chizh B.A., Illes P. P2X receptors and nociception. Pharmacol. Rev. 2001, 53(4):553-568.
9. Christoph T., Gillen C., Mika J., Grünweller A., Schäfer M.K., Schiene K., Frank R., Jostock R., Bahrenberg G., Weihe E., Erdmann V.A., Kurreck J. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1. Neurochem. Int. 2007, 50(1):281-290.
10. Cockayne D.A., Dunn P.M., Zhong Y., Rong W., Hamilton S.G., Knight G.E., Ruan H.Z., Ma B., Yip P., Nunn P., McMahon S.B., Burnstock G., Ford A.P. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol. 2005, 567(Pt 2):621-639.
11. Costa B., Trovato A.E., Comelli F., Giagnoni G., Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharmacol. 2007, 556(1-3):75-83.
12. Eaton M.J., Wolfe S.Q., Martinez M., Hernandez M., Furst C., Huang J., Frydel B.R., Gómez-Marín O. Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic spinal cord injury in the rat. J. Pain 2007, 8(1):33-50.
13. Fujita R., Kiguchi N., Ueda H. LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem. Int. 2007, 50(2):351-355.
14. Gao Q., Yang B., Ye Z.G., Wang J., Bruce I.C., Xia Q. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. Eur. J. Pharmacol. 2007, 574(2-3):179-184.
15. Gao Y., Xu C.S., Liang S.D., Zhang A.X., Mu S.N., Wang Y.X., Wan F. Effect of tetramethylpyrazine on primary afferent transmission mediated receptor in neuropathic pain states by P2X. Brain Res. Bull. 2008, 77(1):27-32.
16. Gao Y., Xu C.S., Yu K.H., Li G.L., Wan F., Liu S.M., Lin J.R., Liu H., Zhang J., Li X., Liang S.D. Effect of tetramethylpyrazine on DRG neuron P2X3 receptor involved in transmitting pain after burn. Burns 2010, 36(1):127-134.
17. Gao Y., Liu H., Deng L.B., Zhu G.H., Xu C.S., Li G.L., Liu S.M., Xie J.Y., Liu J., Kong F.J., Wu R.P., Li G.D., Linag S.D. Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons. Brain Res. Bull. 2011, 84(6):406-413.
18. Glombiewski J.A., Hartwich-Tersek J., Rief W. Depression in chronic back pain patients: prediction of pain intensity and pain disability in cognitive-behavioral treatment. Psychosomatics 2010, 51(2):130-136.
19. Gómez-Villafuertes R., Sánchez-Nogueiro J., Marín-García P., Miras-Portugal M.T. Existence of high and low affinity dinucleotides pentaphosphateinduced calcium responses in individual synaptic terminals and lack of correlation with the distribution of P2X1-7 subunits. Neurochem. Int. 2007, 50(4):628-641.
20. Han D.W., Kweon T.D., Kim K.J., Lee J.S., Chang C.H., Lee Y.W. Does the tibial and sural nerve transection model represent sympathetically independent pain?. Yonsei Med. J. 2006, 47(6):847-851.
21. Jarvis M.F., Burgard E.C., McGaraughty S., Honore P., Lynch K., Brennan T.J., Subieta A., Van Biesen T., Cartmell J., Bianchi B., Niforatos W., Kage K., Yu H., Mikusa J., Wismer C.T., Zhu C.Z., Chu K., Lee C.H., Stewart A.O., Polakowski J., Cox B.F., Kowaluk E., Williams M., Sullivan J., Faltynek C. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(26):17179-17184.
22. Kennedy C. P2X receptors:targets for novel analgesics?. Neuroscientist 2005, 11(4):345-356.
23. Kennedy C., Assis T.S., Currie A.J., Rowan E.G. Crossing the pain barrier: P2 receptors as targets for novel analgesics. J. Physiol. 2003, 553(Part 3):683-694.
24. Lee D.H., Chung K., Chung J.M. Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model. Neuroreport 1997, 8(16):3453-3456.
25. Li G.L., Liu S.M., Zhang J., Yu K.H., Xu C.S., Lin J.R., Li X., Liang S.D. Increased sympathoexcitatory reflex induced by myocardial ischemic nociceptive signaling via P2X2/3 receptor in rat superior cervical ganglia. Neurochem. Int. 2010, 56(8):984-990.
26. Li G.L., Liu S.M., Yang Y., Xie J.Y., Liu J., Kong F.J., Tu G.H., Wu R.P., Li G.D., Liang S.D. Effects of oxymatrine on sympathoexcitatory reflex induced by myocardial ischemic signaling mediated by P2X3 receptors in rat SCG and DRG. Brain Res. Bull. 2011, 84(6):419-424.
27. Liang S.D., Gao Y., Xu C.S., Xu B.H., Mu S.N. Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat. Brain Res. 2004, 995(2):247-252.
28. Liang S.D., Xu C.S., Zhou T., Liu H.Q., Gao Y., Li G.L. Tetramethylpyrazine inhibits ATP-activated currents in rat dorsal root ganglion neurons. Brain Res. 2005, 1040(1-2):92-97.
29. Liang S.D., Xu C.S., Li G.L., Gao Y. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine. Neurochem. Int. 2010, 57(7):705-712.
30. Lin J.R., Li G.L., Den X.R., Xu C.S., Liu S.M., Gao Y., Liu H., Zhang J., Li X., Liang S.D. VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X2(/)3 receptor of primary sensory neurons. Brain Res. Bull. 2010, 83(5):284-291.
31. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82(4):1013-1067.
32. Novakovic S.D., Kassotakis L.C., Oglesby I.B., Smith J.A., Eglen R.M., Ford A.P., Hunter J.C. Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 1999, 80(1-2):273-282.
33. Obara I., Makuch W., Spetea M., Schütz J., Schmidhammer H., Przewlocki R., Przewlocka B. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur. J. Pharmacol. 2007, 558(1-3):60-67.
34. Perl E.R. Ideas about pain, a historical view. Nat. Rev. Neurosci. 2007, 8(1):71-80.
35. Pruimboom L., van Dam A.C. Chronic pain: a non-use disease. Med. Hypotheses 2007, 68(3):506-511.
36. Schmader K.E., Baron R., Haanpää M.L., Mayer J., O'Connor A.B., Rice A.S., Stacey B. Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin. Proc. 2010, 85(Suppl. 3):S26-S32.
37. Shantsila E., Watson T., Lip G.Y.H. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 2007, 49:741-752.
38. Souslova V., Cesare P., Ding Y., Akopian A.N., Stanfa L., Suzuki R., Carpenter K., Dickenson A., Boyce S., Hill R., Nebenuis-Oosthuizen D., Smith A.J., Kidd E.J., Wood J.N. Warm-coding deficits and aberrant inflammatory pain is mice lacking P2X3 receptors. Nature 2000, 407(6807):1015-1017.
39. Szallasi A. Human correlates of animal models of chronic pain. Methods Mol. Biol. 2010, 617:155-157.
40. Tan K.Y., Wu M. Pharmacological effect and adverse effect analysis on puerarin, China. Pharmaceuticals 2007, 16(3):60-61.
41. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70(18):1630-1635.
42. Tyner T.R., Parks N., Faria S., Simons M., Stapp B., Curtis B., Sian K., Yamaguchi K.T. Effects of collagen nerve guide on neuroma formation and neuropathic pain in a rat model. Am. J. Surg. 2007, 193(1):e1-e6.
43. Ueno S., Moriyama T., Honda K., Kamiya H., Sakurada T., Katsuragi T. Involvement of P2X3 and P2X2/3 receptors in neuropathic pain in a mouse model of chronic constriction injury. Drug Dev. Res. 2003, 59(1):104-111.
44. Vadivelu N., Mitra S., Narayan D. Recent advances in postoperative pain management. Yale J. Biol. Med. 2010, 83(1):11-25.
45. Vizi E.S., Sperlagh B. Receptor- and carrier-mediated release of ATP of postsynaptic origin: cascade transmission. Prog. Brain Res. 1999, 120:159-169.
46. Vizi E.S., Sperlagh B., Baranyi M. Evidence that ATP released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Neuroscience 1992, 50(2):455-465.
47. Vizi E.S., Liang S.D., Sperlágh B., Kittel A., Jurányi Z. Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 1997, 79(3):893-903.
48. Vizi E.S., Fekete A., Karoly R., Mike A. Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. Br. J. Pharmacol. 2010, 160(4):785-809.
49. Wan F., Li G.L., Liu S.M., Zhu G.H., Xu C.S., Lin J.R., Zhang J., Li X., Liang S.D. P2X(2/3) receptor activity of rat nodose ganglion neurons contributing to myocardial ischemic nociceptive signaling. Auton. Neurosci. 2010, 158(1-2):58-64.
50. Wang H.J., Zhuang H.R., Zhang X.Y., Fan J.X. Application and therapeutic effect of puerarin in treatment of knee osteoarthritis. Hainan Med. J. 2006, 17(7):95-96.
51. Wang Y.X., Li G.L., Liang S.D., Zhang A.X., Xu C.S., Gao Y., Zhang C.P., Wan F. Role of P2X3 receptor in myocardial ischemia injury and nociceptive sensory transmission. Auton. Neurosci. 2008, 139(1-2):30-37.
52. Wang Y.X., Li G.L., Yu K.H., Liang S.D., Wan F., Xu C.S., Gao Y., Liu S.M., Lin J.R. Expression of P2X2 and P2X3 receptors in rat nodose neurons after myochcardial ischemia injury. Auton. Neurosci. 2009, 145(1-2):71-75.
53. Wirkner K., Sperlagh B., Illes P. P2X(3) receptor involvement in pain states. Mol. Neurobiol. 2007, 36(2):165-183.
54. Xiao L.Z., Huang Z., Ma S.C., Zen Z., Luo B., Lin X., Xu X. Study on the effect and mechanism of puerarin on the size of infarction in patients with acute myocardial infarction. Chin. J. Integr. Tradit. Western Med. 2004, 24(9):790-792.
55. Xu C.S., Li G.L., Gao Y., Liu S.M., Lin J.R., Zhang J., Li X., Liu H., Liang S.D. Effect of puerarin on P2X3 receptor involved in hyperalgesia after burn injury in the rat. Brain Res. Bull. 2009, 80(6):341-346.
56. Yeung D.K., Leung S.W., Xu Y.C., Vanhoutte P.M., Man R.Y. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur. J. Pharmacol. 2006, 552(1-3):105-111.
57. Zhang A.X., Xu C.S., Liang S.D., Gao Y., Li G.L., Wan F., Liu S.M., Lin J.R. Role of sodium ferulate in the nociceptive sensory facilitation of neuropathic pain injury mediated by P2X3 receptor. Neurochem. Int. 2008, 53(6-8):278-282.
58. Zhang A.X, Gao Y., Zhong X.Q., Xu C.S., Li G.L., Liu S.M., Lin J.R., Li X., Zhang Y., Liu H., Liang S.D. Effect of sodium ferulate on the hyperalgesia mediated by P2X3 receptor in the neuropathic pain rats. Brain Res. 2010, 1313:215-221.
59. Zhou J., Fang S.P., Qi Y., Huo H.R., Jiang T.L., Shi Q. Effect of GeGen decoction on inflammatory media in joint of adjuvant arthritis rats. Chin. J. Exp. Tradit. Med. Form. 2001, 7(3):29-31.